Prostate cancer affects the prostate, a walnut-size gland in men that surrounds the urethra and normally helps produce seminal fluid. Unlike other cancer types, prostate cancer sometimes grows very slowly. If it's an early-stage cancer, it may be safe to use "watchful waiting" or "active surveillance" to monitor the cancer and delay treatment unless it gets bigger or more threatening. Prostate cancer treatments include radiation, surgery, and hormone therapy, which can have side effects such as erectile dysfunction or incontinence.
Prostate Cancer News
By Randy DotingaHealthDay Reporter TUESDAY, June 30, 2015 (HealthDay News) — A wide majority of U.S. men with low-risk prostate cancer are being treated for the disease even though “active surveillance” is an option, a new report finds. Active surveillance — or watchful waiting — is the careful monitoring of prostate cancer for progression of the cancer [...]
MONDAY, June 1, 2015 (HealthDay News) — Prostate cancer patients with an unhealthy, high-fat diet have a significantly higher risk of death from the disease, a new study suggests. “There is currently very little evidence to counsel men living with prostate cancer on how they can modify their lifestyle to improve survival. Our results suggest that [...]
By Steven ReinbergHealthDay Reporter FRIDAY, May 29, 2015 (HealthDay News) — Radiation therapy for prostate cancer may be less effective for overweight and obese men than for men of normal weight, a new study suggests. Higher rates of prostate cancer relapse, prostate cancer death, and death from other causes were seen for overweight and obese men in [...]
FRIDAY, May 22, 2015 (HealthDay News) — A new study suggests, but does not prove, that men with asthma may be less likely to develop aggressive prostate cancer or to die from the disease. Researchers found that men with asthma were 29 percent less likely to develop aggressive prostate cancer. And they were 36 percent less [...]
Fewer American men are receiving prostate cancer screening in the wake of a national panel’s conclusion that the test does men more harm than good, a new study finds.